Actual Medicinal Product (AMP) Olmesartan medoxomil 20mg / Hydrochlorothiazide 12.5mg tablets (Alliance Healthcare (Distribution) Ltd)

Stability Information

(Some stability information inherited from generic)

Stability
compatible logo Suitable for use in MCAs, although use is likely to be off-label. Keep medicines in MCAs for the shortest time necessary. Generally, up to 5 weeks maximum unless otherwise specified, or up to 8 weeks if the MCA is airtight (sealed). Consider the risk of potency loss or dose variability and monitor for changes in efficacy or adverse effects after MCA initiation.
Notes

No stability data in MCAs available but no theoretical concerns with product.

Provenance

This recommendation is based on the products Olmetec Plus 20mg/12.5 mgtablets (Daiichi Sankyo UK Limited) and olmesartan/hydrochlorothiazide 20mg/12.5mg tablets (Thornton & Ross Ltd).

Generic
Olmesartan + Hydrochlorothiazide
Formulation
Olmesartan medoxomil 20mg / Hydrochlorothiazide 12.5mg tablets
  • Olmesartan + Hydrochlorothiazide
    • Olmesartan medoxomil 20mg / Hydrochlorothiazide 12.5mg tablets

      • Olmesartan medoxomil 20mg / Hydrochlorothiazide 12.5mg tablets (Alliance Healthcare (Distribution) Ltd)